Reimagining vaccine delivery with oral tablet immunization
Vaccine Insights · 30.03.2026 · 5 (2) · 76–80
DOI: 10.18609/vac.2026.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccine Insights, online erschienen am 30.03.2026. Verfasst von Sean Tucker. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
“we built an adjuvant system where a double‑stranded RNA hairpin is co‑expressed along with the protein of interest to generate a strong immune response.”Charlotte Barker, Editor, Vaccine Insights, speaks with Sean Tucker, Founder and Chief Scientific Officer, Vaxart, about the scientific and translational journey behind the company's oral tablet vaccines and the use of controlled human infection models to refine immune correlates.
Zitieren
APA
Tucker, S. (2026). Reimagining vaccine delivery with oral tablet immunization. Vaccine Insights, 5(2), 76–80. https://doi.org/10.18609/vac.2026.016
Vancouver
Tucker S. Reimagining vaccine delivery with oral tablet immunization. Vaccine Insights. 2026;5(2):76–80. doi:10.18609/vac.2026.016
BibTeX
@article{Tucker2026,
author = {Tucker, Sean},
title = {Reimagining vaccine delivery with oral tablet immunization},
journal = {Vaccine Insights},
year = {2026},
volume = {5},
number = {2},
pages = {76–80},
doi = {10.18609/vac.2026.016}
}
EUVIMED